Tag Archives: venture capital

Bridging the Valley of Death: Bringing New Drugs from the Bench to the Clinic

To bring a new medicine to the stage of clinical trial testing requires on the order of $500,000 to one million dollars and then seven to ten years of clinical trials and around $800 million dollars before getting to market.  … Continue reading

Posted in Clinical Trials, Venture Capital | Tagged , , , , , , , , , , , , | Comments Off

Conference Recap – BayBio 2011

The BayBio Annual Conference 2011 was held on 20-21 April 2011 in Burlingame, CA.  The event was attended by more than 1,000 San Francisco Bay Area biotech and life sciences professionals from over 400 companies. This year’s conference focused on … Continue reading

Posted in Conferences and Meetings, Venture Capital | Tagged , , , , , , , , , , , , , , , , , | Comments Off

Recap of the 20th CED Biotech/Life Sciences Conference

The 20th Annual Council for Entrepreneurial Development (CED) Biotech/Life Science Conference was held on 21-22 February 2011 in Raleigh, North Carolina. Continue reading

Posted in Conferences and Meetings, Industry News, Venture Capital | Tagged , , , , , , , , , , , , | Comments Off

Biotech Financing: Those That Adapt to Change Will Survive

In the October issue of Biotechnology Focus, Cato Research’s very own Chief Financial Officer and Principal of Cato BioVentures, Daniel Pharand, discusses the recent shift and latest trends in financing within the biotechnology industry.  “There have been a number of … Continue reading

Posted in Publications, Venture Capital | Tagged , , , , | 1 Comment

2010 Mid-Atlantic Bio Conference

Image via Wikipedia The 2010 Mid-Atlantic Bio conference will be held in Bethesda, MD from Wednesday, 27 October to Friday, 29 October.  Mid-Atlantic Bio is now in its sixth year and has become one of the country’s premier bioscience and … Continue reading

Posted in Conferences and Meetings, Venture Capital | Tagged , , , , , , | Comments Off